Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laxman Devkota

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology|February 13, 2025
Nanoparticle Contrast Agents for Photon-Counting Computed Tomography: Recent Developments and Future OpportunitiesLaxman Devkota, Rohan Bhavane, Cristian T Badea, et al.
Science Advances|August 25, 2020
Detection of response to tumor microenvironment-targeted cellular immunotherapy using nano-radiomicsLaxman Devkota, Zbigniew Starosolski, Charlotte H Rivas, et al.
Contrast Media & Molecular Imaging|December 13, 2018
A Hyperfluorinated Hydrophilic Molecule for Aqueous <sup>19</sup>F MRI Contrast MediaEric A Tanifum, Laxman Devkota, Conelius Ngwa, et al.
Medrxiv : the Preprint Server for Health Sciences|March 30, 2023
Feasibility Study of Ferumoxtyol for Contrast-enhanced MRI of Retroplacental Clear Space Disruption in Placenta Accreta Spectrum (PAS)Andrew A Badachhape, Brian Burnett, Prajwal Bhandari, et al.
Scientific Reports|October 1, 2020
Pre-clinical dose-ranging efficacy, pharmacokinetics, tissue biodistribution, and toxicity of a targeted contrast agent for MRI of amyloid deposition in Alzheimer's diseaseAndrew A Badachhape, Peter K Working, Mayank Srivastava, et al.
Academic Radiology|September 27, 2022
Nanoparticle Contrast-enhanced MRI for Visualization of Retroplacental Clear Space Disruption in a Mouse Model of Placental Accreta Spectrum (PAS)Andrew A Badachhape, Prajwal Bhandari, Laxman Devkota, et al.
Theranostics|August 1, 2022
A surrogate marker for very early-stage tau pathology is detectable by molecular magnetic resonance imagingParag Parekh, Qingshan Mu, Andrew Badachhape, et al.
Scientific Reports|December 12, 2019
Nanoparticle Contrast-enhanced T1-Mapping Enables Estimation of Placental Fractional Blood Volume in a Pregnant Mouse ModelAndrew A Badachhape, Laxman Devkota, Igor V Stupin, et al.
Theranostics|March 17, 2025
Nanoparticle contrast-enhanced computed tomography of sporadic aortic aneurysm and dissection: Effect of nanoparticle size and contrast agent doseLaxman Devkota, Chen Zhang, Deborah Vela, et al.
Placenta|January 9, 2025
Ferumoxytol-enhanced MRI of retroplacental clear space disruption in placenta accreta spectrumAndrew A Badachhape, Brian Burnett, Prajwal Bhandari, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology|February 13, 2025
Nanoparticle Contrast Agents for Photon-Counting Computed Tomography: Recent Developments and Future OpportunitiesLaxman Devkota, Rohan Bhavane, Cristian T Badea, et al.
Science Advances|August 25, 2020
Detection of response to tumor microenvironment-targeted cellular immunotherapy using nano-radiomicsLaxman Devkota, Zbigniew Starosolski, Charlotte H Rivas, et al.
Contrast Media & Molecular Imaging|December 13, 2018
A Hyperfluorinated Hydrophilic Molecule for Aqueous <sup>19</sup>F MRI Contrast MediaEric A Tanifum, Laxman Devkota, Conelius Ngwa, et al.
Medrxiv : the Preprint Server for Health Sciences|March 30, 2023
Feasibility Study of Ferumoxtyol for Contrast-enhanced MRI of Retroplacental Clear Space Disruption in Placenta Accreta Spectrum (PAS)Andrew A Badachhape, Brian Burnett, Prajwal Bhandari, et al.
Scientific Reports|October 1, 2020
Pre-clinical dose-ranging efficacy, pharmacokinetics, tissue biodistribution, and toxicity of a targeted contrast agent for MRI of amyloid deposition in Alzheimer's diseaseAndrew A Badachhape, Peter K Working, Mayank Srivastava, et al.
Academic Radiology|September 27, 2022
Nanoparticle Contrast-enhanced MRI for Visualization of Retroplacental Clear Space Disruption in a Mouse Model of Placental Accreta Spectrum (PAS)Andrew A Badachhape, Prajwal Bhandari, Laxman Devkota, et al.
Theranostics|August 1, 2022
A surrogate marker for very early-stage tau pathology is detectable by molecular magnetic resonance imagingParag Parekh, Qingshan Mu, Andrew Badachhape, et al.
Scientific Reports|December 12, 2019
Nanoparticle Contrast-enhanced T1-Mapping Enables Estimation of Placental Fractional Blood Volume in a Pregnant Mouse ModelAndrew A Badachhape, Laxman Devkota, Igor V Stupin, et al.
Theranostics|March 17, 2025
Nanoparticle contrast-enhanced computed tomography of sporadic aortic aneurysm and dissection: Effect of nanoparticle size and contrast agent doseLaxman Devkota, Chen Zhang, Deborah Vela, et al.
Placenta|January 9, 2025
Ferumoxytol-enhanced MRI of retroplacental clear space disruption in placenta accreta spectrumAndrew A Badachhape, Brian Burnett, Prajwal Bhandari, et al.
Pageof 2